2. Academic Validation
  3. Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents

Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents

  • Bioorg Med Chem. 2018 Feb 1;26(3):630-636. doi: 10.1016/j.bmc.2017.12.027.
Ying Wang 1,  Shao-Ru Chen 2,  Xiaoming Yang 3,  Kuo-Hsiung Lee 4,  Yung-Chi Cheng 5
Affiliations

Affiliations

  • 1 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, United States; Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau.
  • 2 Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau.
  • 3 Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States.
  • 4 Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States; Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan. Electronic address: khlee@unc.edu.
  • 5 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, United States. Electronic address: yccheng@yale.edu.
PMID: 29317151 DOI: 10.1016/j.bmc.2017.12.027
Abstract

The tylophorine analog rac-cryptopleurine exhibited potent anti-hepatitis C virus (HCV) activity through allosteric regulation of ATPase activity of heat shock cognate protein 70 (Hsc70). We evaluated the impact of modifications on the E-ring of rac-cryptopleurine to the inhibitory activity against HCV replication and regulation of ATPase activity of Hsc70. Cryptopleurine analog YXM-110 with a 13α-hydroxyl group maintained activity against HCV and promoted ATP/ADP turnover of Hsc70; however, compounds with hydroxyl groups at Other positions or with Other orientations (YXM-109, YXM-139, and YXM-140) did not exhibit similar activities. Size modification or heteroatom incorporation of the E-ring led to loss of anti-HCV activity. Promotion of the chaperone activity of Hsc70 with carboxyl terminus Hsc70 interacting protein (CHIP) further enhanced the anti-HCV activity of rac-cryptopleurine and XYM-110. This structure-activity relationship (SAR) study refined structural design and optimization for developing rac-crytopleurine analogs as potent anti-HCV agents targeted against the host factor involved in HCV replication.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z